Freedom SOLO Stentless Heart Valve Study

NCT01115907 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 251

Last updated 2015-01-26

No results posted yet for this study

Summary

The purpose of this clinical investigation is to demonstrate the safety and effectiveness of the Freedom SOLO heart valve.

Conditions

  • Aortic Stenosis
  • Aortic Insufficiency

Interventions

DEVICE

Freedom SOLO Stentless Heart Valve

Freedom SOLO Stentless Heart Valve

Sponsors & Collaborators

  • Sorin Group USA, Inc.

    lead INDUSTRY

Principal Investigators

  • Eric Roselli, M.D. · The Cleveland Clinic

  • David Heimansohn, MD · St. Vincent Heart Center

  • Alex Zapolanski, MD · The Valley Hospital

  • Vinod Thourani, MD · Emory University

  • Reza Dabir, MD · Oakwood Hospital

  • Ali Khoynezhad, MD · Cedars-Sinai Medical Center

  • Pranshanth Vallabhajosyula, MD · University of Pennsylvania

  • Michael Moront, MD · The Toledo Hospital

  • Scott Goldman, MD · Main Line Health

  • Shaohua Wang, MD · University of Alberta

  • L. Ray Guo, MD · London Health Science Centre

  • Andrew Maitland, MD · Foothills Medical Center

  • Michael Moon, MD · St. Boniface Hospital

  • Pierre Voisine, MD · Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

  • Jian Ye, MD · St. Paul's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01115907 on ClinicalTrials.gov